help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krikun, G.
Right arrow Articles by Lockwood, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krikun, G.
Right arrow Articles by Lockwood, C. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 3 926-930
Copyright © 1998 by The Endocrine Society


Original Studies

Transcriptional Regulation of the Tissue Factor Gene by Progestins in Human Endometrial Stromal Cells1

Graciela Krikun, Frederick Schatz, Nigel Mackman, Seth Guller and Charles J. Lockwood

Departments of Obstetrics and Gynecology (G.K., S.G., C.J.L.) and Biochemistry (S.G.), New York University Medical Center, New York, New York 10016; and Departments of Immunology and Vascular Biology, The Scripps Research Institute (N.M.), La Jolla, California 92037

Address all correspondence and requests for reprints to: Dr. Graciela Krikun, New York University Medical Center, Tisch Hospital, Room 533, 550 First Avenue, New York, New York 10016.

Decidualization of estradiol (E2)-primed human endometrial cells (HESCs) by progesterone is associated with elevated levels of tissue factor (TF), the primary initiator of hemostasis. Similarly, in cultured human HESCs, the synthetic progestin, medroxyprogesterone acetate (MPA), enhances TF protein and messenger ribonucleic acid (mRNA) levels. Although ineffective alone, E2 potentiates this progestin enhancement of TF expression by HESCs. The current study examines mechanisms underlying MPA enhancement of TF mRNA expression in HESCs. In the presence of the transcription-blocking agent dichlororibofuranosylbenzimidazole, no significant differences were noted in the half-lives of TF mRNA isolated from HESCs treated with E2 alone or with E2 plus MPA. This indicates that MPA-enhanced TF mRNA levels do not reflect changes in the stability of the TF message. To test the effect of progestin on TF promoter activity and to ascertain the mechanism of promoter regulation, primary or first passaged HESCs were transfected with TF promoter constructs spanning the regions -2106 to +121 (TFp-2106), -278 to +121 (TFp-278), and -111 to +14 (TFp-111) bp upstream of the transcription start site. MPA was found to enhance TF transcription by 20-fold in HESCs transfected with TFp-2106 after correcting for transfection efficiencies with a ß-galactosidase reporter plasmid. Interestingly, levels of E2- plus MPA-stimulated transcription were significantly increased using TFp-278 compared to TFp-2106, suggesting that the region between -2106 and -278 bp may contain an inhibitory element. In addition, rates of MPA-stimulated transcription using TFp-111 were significantly reduced compared to values obtained using TFp-2106 and were even further reduced compared to values obtained using TFp-278. This suggests that regulatory elements in the -111 bp region of the TF promoter are necessary for progestin-mediated regulation of the TF gene in HESCs, but are not sufficient to account for maximal rates of TF gene transcription.

Our results also demonstrated that induction of steady state TF mRNA by MPA was abolished by treating cells with E2 plus MPA in conjunction with the protein synthesis inhibitor cycloheximide. In light of the absence of a complete progesterone or estrogen response element in the published 5'-sequence of the TF promoter, our results suggest that progestin-enhanced transcription of TF mRNA in stromal cells may be mediated by an uncharacterized protein intermediate(s).




This article has been cited by other articles:


Home page
Reproductive SciencesHome page
G. Krikun and C. J. Lockwood
Steroid Hormones, Endometrial Gene Regulation and the Sp1 Family of Proteins
Reproductive Sciences, November 1, 2002; 9(6): 329 - 334.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
J. Biol. Chem., February 8, 2002; 277(7): 5209 - 5218.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
H. Okada, T. Nakajima, T. Yoshimura, K. Yasuda, and H. Kanzaki
The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro
Mol. Hum. Reprod., April 1, 2001; 7(4): 341 - 347.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Okada, T. Nakajima, M. Sanezumi, A. Ikuta, K. Yasuda, and H. Kanzaki
Progesterone Enhances Interleukin-15 Production in Human Endometrial Stromal Cells in Vitro
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4765 - 4770.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Runic, F. Schatz, L. Wan, R. Demopoulos, G. Krikun, and C. J. Lockwood
Effects of Norplant on Endometrial Tissue Factor Expression and Blood Vessel Structure
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3853 - 3859.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
G. Krikun, F. Schatz, N. Mackman, S. Guller, R. Demopoulos, and C. J. Lockwood
Regulation of Tissue Factor Gene Expression In Human Endometrium by Transcription Factors Sp1 and Sp3
Mol. Endocrinol., March 1, 2000; 14(3): 393 - 400.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. J. Lockwood, G. Krikun, R. Runic, L. B. Schwartz, A. F. Mesia, and F. Schatz
Progestin-Epidermal Growth Factor Regulation of Tissue Factor Expression during Decidualization of Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 297 - 301.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
S. Okada, H. Okada, M. Sanezumi, T. Nakajima, K. Yasuda, and H. Kanzaki
Expression of interleukin-15 in human endometrium and decidua
Mol. Hum. Reprod., January 1, 2000; 6(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. E. Mendelsohn and R. H. Karas
The Protective Effects of Estrogen on the Cardiovascular System
N. Engl. J. Med., June 10, 1999; 340(23): 1801 - 1811.
[Full Text] [PDF]


Home page
Mol Hum ReprodHome page
H. Okada, M. Sanezumi, T. Nakajima, S. Okada, K. Yasuda, and H. Kanzaki
Rapid down-regulation of CD63 transcription by progesterone in human endometrial stromal cells
Mol. Hum. Reprod., June 1, 1999; 5(6): 554 - 558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society